Sign In
Buy NUVB
Nuvation Bio Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be positive at 16.09. In total, the insiders bought 17.87M and sold 1.85M NUVB shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
16.09 |
| ● Buy | 17.87M shares |
| ● Sell | 1.85M shares |
|
84% Buy Activity
Strong Negative Correlation
|
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
May 21, 2026 Buy |
Cui Xiangmin Director |
123 397 Value: $591.1K |
||
|
May 21, 2026 Buy |
Bazemore Robert B Director |
123 397 Value: $591.1K |
||
|
May 21, 2026 Buy |
Blickenstaff Kim D Director |
123 397 Value: $591.1K |
||
|
May 21, 2026 Buy |
Falberg Kathryn E Director |
123 397 Value: $591.1K |
||
|
May 21, 2026 Buy |
Mashal Robert Director |
123 397 Value: $591.1K |
||
|
May 21, 2026 Buy |
Vernon W Anthony Director |
123 397 Value: $591.1K |
||
|
Apr 17, 2026 Buy |
Wentworth Kerry Chief Regulatory Officer |
36 750 Value: $107.7K |
||
|
Apr 17, 2026 Buy |
Wentworth Kerry Chief Regulatory Officer |
36 750 Value: $107.7K |
||
|
Apr 17, 2026 Sell |
Wentworth Kerry Chief Regulatory Officer |
36 750 Value: $184.3K |
||
|
Apr 17, 2026 Buy |
Liu Dongfang Chief Medical Officer |
50 000 Value: $97.0K |
||
|
Apr 17, 2026 Buy |
Liu Dongfang Chief Medical Officer |
50 000 Value: $97.0K |
||
|
Apr 17, 2026 Sell |
Liu Dongfang Chief Medical Officer |
50 000 Value: $251.0K |
||
|
Apr 06, 2026 Buy |
Wentworth Kerry Chief Regulatory Officer |
100 000 Value: $194.0K |
||
|
Apr 06, 2026 Buy |
Wentworth Kerry Chief Regulatory Officer |
100 000 Value: $187.0K |
||
|
Apr 06, 2026 Buy |
Wentworth Kerry Chief Regulatory Officer |
100 000 Value: $194.0K |
||
|
Apr 06, 2026 Buy |
Wentworth Kerry Chief Regulatory Officer |
100 000 Value: $187.0K |
||
|
Apr 06, 2026 Sell |
Wentworth Kerry Chief Regulatory Officer |
200 000 Value: $903.6K |
||
|
Feb 27, 2026 Buy |
Cui Xiangmin Director |
76 923 Value: $454.6K |
||
|
Feb 27, 2026 Buy |
Hung David President And CEO |
1 995 012 Value: $11.8M |
||
|
Feb 27, 2026 Buy |
Cui Xiangmin Director |
74 813 Value: $442.1K |
||
|
Feb 27, 2026 Buy |
Markel Stacy Chief People Officer |
748 130 Value: $4.42M |
||
|
Feb 27, 2026 Buy |
Makunje Moses See Remarks |
50 761 Value: $300.0K |
||
|
Feb 27, 2026 Buy |
Makunje Moses See Remarks |
224 439 Value: $1.33M |
||
|
Feb 27, 2026 Buy |
Liu Dongfang Chief Medical Officer |
748 130 Value: $4.42M |
||
|
Feb 27, 2026 Buy |
Wentworth Kerry Chief Regulatory Officer |
748 130 Value: $4.42M |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
